Immuno-Oncology Assay Market Size & Insights

The Global Immuno-Oncology Assay Market size was valued at around USD 3.62 billion in 2024 and is projected to reach USD 6.86 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.25% during the forecast period, i.e., 2025-30.

The market growth has been supported by several factors reshaping the cancer diagnosis and treatment landscape. One of the primary factors has been the escalating global cancer incidence, which has led to the critical need for more precise diagnostic tools and effective therapeutic strategies.

What are the Key DROs in the Immuno-Oncology Assay Market?

Rising Cancer Cases Globally to Drive Immuno-Oncology Assay – The substantial growth in the Global Immuno-Oncology Assay Market has been attributed to the increasing prevalence of cancer globally. The global incidence of cancer has risen significantly, with notable increases reported in countries such as the US and India, as documented by leading healthcare organizations like the World Health Organization, the International Agency for Research on Cancer, and the Global Cancer Observatory.

What are the Key Segments in the Immuno-Oncology Assay Market?

The Immuno-Oncology Assay is categorized into notable segments, which help in understanding the structure, dynamics, and opportunities within the market. These segments are typically based on:

By Product & Services

• Reagents and Antibodies
• Testing Kits
• Instruments
• Consumables & Accessories
• Software

Among them, reagents and antibodies are pivotal components that play a significant role in cancer diagnosis and monitoring, owing to which, they have been dominating the Global Immuno-Oncology Assay Market over the historical years. Reagents and antibodies hold strategic importance within the market as they are essential components in diagnostic assay

By Assay Type

• Checkpoint Inhibitor Assays
• Cytokine Profiling Assays
• Protein Biomarker Assays
• Genomic Sequencing and Mutational Analysis
• Immune Profiling Assays
• Tumour Biomarker Assays
• Others (Gene Expression Profiling Assays, Multiplex Assays, etc.)

Boost Your Company's Decisions by Getting a Free Sample Right Away-   https://www.marknteladvisors.com/query/request-sample/immuno-oncology-assay-market.html

By Technology

• Polymerase Chain Reaction
• Immunoassay
• Next-generation Sequencing
• In-situ Hybridization
• Flow Cytometry
• Others (Mass Spectrometry, Immunohistochemistry (IHC), etc.)

By Indication

• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Ovarian Cancer
• Others (Bladder Cancer, Melanoma, etc.)

By Application

• Clinical Assay
• Research & Development

By End User

• Hospitals
• Cancer Research Centers
• Specialty Cancer Clinics
• Clinical Laboratories
• Others (Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), etc.)

How does geographical analysis highlight in the Immuno-Oncology Assay market?

By Country

• China
• India
• Japan
• South Korea
• Australia
• Rest of Asia-Pacific

North America's pre-eminence in the global Immuno-Oncology Assay Market is underpinned by a multifaceted landscape shaped by various factors. 

Who are the Key Players in Immuno-Oncology Assay Market?

• Agilent Technologies Inc.
• Aviva Systems Biology Corporation
• PerkinElmer Inc.
• Bio-Rad Laboratories, Inc.
• Illumina Inc.
• Qiagen N.V.
• Thermo Fisher Scientific, Inc.
• Sartorius AG
• NanoString Technologies, Inc.
• BioGenex
• Abbott Laboratories, Inc.
• Asuragen Inc.
• Meso Scale Assay, LLC
• Merck Millipore
• Enzo Biochem Inc.and others.
  
  

Browse Full Reports - https://www.marknteladvisors.com/research-library/immuno-oncology-assay-market.html

Immuno-Oncology Assay Market News

• 2025: Agilent Technologies Inc. announced an extended partnership with Incyte to boost the development and commercialization of Incyte’s hematology and oncology portfolio. This collaboration focuses on incorporating advanced assay technologies to support precision diagnostics and targeted therapies.

Key pillars of the research methodology include:

• Scope & Research Design – Clearly defined objectives with tailored qualitative and quantitative methods, backed by precise timelines and budgets.
• Sample Selection & Data Collection – Representative samples achieved through proven techniques like random and stratified sampling, supported by reliable tools such as surveys, interviews, and observations.
• Data Analysis & Validation – Rigorous cleaning, advanced statistical modeling, and thematic analysis ensure accuracy, reliability, and minimal bias.
• Forecasting & Finalization – Predictive modeling and time-series analysis anticipate future market behaviors, presented through insightful reports with charts, graphs, and strategic recommendations.

"Our methodology reflects the trust businesses place in us. By combining innovation with precision, we deliver not just numbers, but clarity and direction for decision-makers worldwide," said a spokesperson for MarkNtel Advisors.

Other reports:
Evaluating the Significantly Growing Ovarian Cancer Market

How Lucrative is the Future of the Li-Fi Market?

Why This MarkNtel Advisors Research Report:

• In-depth Market Analysis: Understand trends and dynamics shaping growth.
• Segmented Insights: Target specific segments for focused strategies.
• Geographical Performance: Assess market opportunities by geographic area.
• Emerging Technologies: Discover advancements like AI integration.
• Risk Identification: Pinpoint challenges to inform strategic planning.
• Future Forecasts: Prepare for market changes with actionable projections.

Gain exclusive access to our comprehensive insights on the Future of Immuno-Oncology Assay Market. With tailored licensing options, including Mini Report Pack, Excel Data Pack, Single User, Multiuser, and Enterprise Packs, our research empowers organizations to navigate dynamic market trends effectively.

Select a License That Matches Your Business Requirements with Instant Offer - https://www.marknteladvisors.com/pricing/immuno-oncology-assay-market.html

Our Trusted Experts Are Here to Help:

At MarkNtel Advisors, we are committed to delivering data-driven insights and strategic intelligence that empower your business decisions. Whether you have a question, need customized research, or want to explore partnership opportunities, our team is here to support you every step of the way.

Reach Us:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Visit our Website: https://www.marknteladvisors.com

We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.